Singapore plans to reduce guaranteed funds for biomedical scientists in order to increase the return on investments. Currently, the Agency for Science, Technology and Research guarantees 100% funding. Under the new policy, which takes effect April 1 and will be in place for at least a year, Singapore’s biomedical research institutes will vie for 30% […]
Cuts in France’s 2011 budget were recently announced, and the only two ministries to dodge the cuts were the ministry of science and education and the justice ministry. In the wake of the budget announcement, Minister for Research and Higher Education Valérie Pécresse announced that her ministry’s budget will be €4.7 billion ($6.5 billion) more […]
The World Steel Association’s October 2010 short-range outlook for 2010 and 2011 forecasts that global apparent steel use (deliveries of steel from domestic producers and importers and not from inventories) will increase 13.1% to 1,272 million metric tons (mmt) in 2010 after decreasing by 6.6% last year. World steel demand is expected to grow 5.3% […]
Second-quarter revenues for IBO’s Lab Equipment/Consumables Sales Index grew 4.6%, 4.7% excluding currency, to $4,183.68 million. While most companies reported increased revenue growth due to the general economic recovery, certain businesses were still negatively impacted by capital restrains. Operating profits for the Index climbed 13.7% to $709.32 million, and adjusted operating margins improved 140 basis […]
IMS Health forecasts the global pharmaceutical market will reach $880 billion in 2011, growing 5%–7%, compared with 4%–5% in 2010. The overall market is projected to rebound, but factors that prohibit growth, including major patent expirations and payer mechanisms to curb drug spending, will be stronger than ever. Drug sales in the 17 pharmerging countries […]
Cambridge, MA 10/14/10; Washington, DC 10/15/10—Helicos BioSciences has appointed Dr. Ivan Trifunovich as president and CEO. He served as a senior consultant to the Board and was elected executive chairman last month. Previously, he served as senior vice president of molecular diagnostics firm Third Wave Technologies. Helicos BioSciences also announced the launch of a technology-licensing […]
Cleveland, OH 10/1/10; Quebec City, Canada 10/1/10—EXFO has sold its Life Sciences and Industrial Division to private equity firm The Riverside Company for $24.3 million in cash. The business supplies high-intensity UV illumination products, which are used in microscopes and life science instruments, as well as curing products. It will be renamed the Lumen Dynamics […]
San Diego, CA and Ottawa, Canada 10/14/10—Fate Therapeutics announced that it has signed a three-year collaboration and licensing agreement with BD Biosciences for the development and commercialization of induced pluripotent stem cell technologies for drug discovery and development. The companies will jointly develop products that BD Biosciences will commercialize. The agreement includes exclusive licenses to […]
Santa Clara, CA 10/13/10—Cell Biosciences has agreed to acquire Convergent Bioscience for $12 million in cash. Convergent Bioscience provides systems based on imaging capillary electrophoresis for quality control measurements during protein biologics production. Based in Toronto, Canada, Convergent Bioscience has 45 employees and is expected to have 2010 revenues of close to $8 million. “Our […]
Hopkinton, MA 10/12/10—Caliper Life Sciences announced that it has renewed its supply agreement with Agilent Technologies for microfluidic chips. Caliper will be Agilent’s exclusive supplier for seven years. “Agilent represents our largest OEM customer and accounted for over 15% of our total microfluidics business in 2009,” said Caliper President and CEO Kevin Hrusovsky. “We expect […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
